P3.16-36 Adjuvant Chemotherapy May Improve the Outcome of Patients With Non-Small-Cell Lung Cancer With Metastasis of Intrapulmonary Lymph Nodes.

Journal of Thoracic Oncology- United States

doi 10.1016/j.jtho.2018.08.1943

Full Text

Abstract

Available in

Categories

Respiratory Medicine

Date

October 1, 2018

Authors

Publisher

Elsevier BV

Related search

P2.16-45 Should Patients With Stage IB Non-Small Cell Lung Cancer Receive Adjuvant Chemotherapy?

Journal of Thoracic Oncology

Respiratory Medicine

English

Effect of Mediastinal Lymph Nodes Sampling in Patients With Clinical Stage I Non-Small Cell Lung Cancer

Journal of Medical Investigation

Molecular Biology

English

P2.16-36 Adjuvant Chemotherapy Is Effective for Completely Resected Stage IB Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English

P3.16-25 Impact of Diabetes Mellitus on Survival Outcome in Patients With Pathological Stage IA Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English

P3.16-24 Prognostic Value of Positive Lymph Node Ratio in Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English

P3.16-29 Prediction of Lymph Node Metastases in Clinical T1aN0M0 Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English

Oncologic Treatment of Non-Small Cell Lung Cancer Part B: Adjuvant Chemotherapy for Resected Non-Small Cell Lung Carcinoma

English

Preoperative Platelet Count in Predicting Lymph Node Metastasis and Prognosis in Patients With Non-Small Cell Lung Cancer

Cancer Research

English

Nursing Care for Patients With Non-Small Cell Lung Cancer Receiving Adjuvant Chemotherapy: Evidence–based Implications for Practice

Canadian Oncology Nursing Journal

English